Request for Covid-19 Impact Assessment of this Report
The United States Bulk Drug Intermediates market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bulk Drug Intermediates market, reaching US$ million by the year 2028. As for the Europe Bulk Drug Intermediates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bulk Drug Intermediates players cover Lonza, Catalent, Patheon, and Jubilant, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bulk Drug Intermediates market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
GMP
Non-GMP
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Antibiotics
Antipyretic Analgesics
Vitamins
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bulk Drug Intermediates Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bulk Drug Intermediates by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bulk Drug Intermediates by Country/Region, 2017, 2022 & 2028
2.2 Bulk Drug Intermediates Segment by Type
2.2.1 GMP
2.2.2 Non-GMP
2.3 Bulk Drug Intermediates Sales by Type
2.3.1 Global Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
2.3.2 Global Bulk Drug Intermediates Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bulk Drug Intermediates Sale Price by Type (2017-2022)
2.4 Bulk Drug Intermediates Segment by Application
2.4.1 Antibiotics
2.4.2 Antipyretic Analgesics
2.4.3 Vitamins
2.4.4 Others
2.5 Bulk Drug Intermediates Sales by Application
2.5.1 Global Bulk Drug Intermediates Sale Market Share by Application (2017-2022)
2.5.2 Global Bulk Drug Intermediates Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bulk Drug Intermediates Sale Price by Application (2017-2022)
3 Global Bulk Drug Intermediates by Company
3.1 Global Bulk Drug Intermediates Breakdown Data by Company
3.1.1 Global Bulk Drug Intermediates Annual Sales by Company (2020-2022)
3.1.2 Global Bulk Drug Intermediates Sales Market Share by Company (2020-2022)
3.2 Global Bulk Drug Intermediates Annual Revenue by Company (2020-2022)
3.2.1 Global Bulk Drug Intermediates Revenue by Company (2020-2022)
3.2.2 Global Bulk Drug Intermediates Revenue Market Share by Company (2020-2022)
3.3 Global Bulk Drug Intermediates Sale Price by Company
3.4 Key Manufacturers Bulk Drug Intermediates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bulk Drug Intermediates Product Location Distribution
3.4.2 Players Bulk Drug Intermediates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bulk Drug Intermediates by Geographic Region
4.1 World Historic Bulk Drug Intermediates Market Size by Geographic Region (2017-2022)
4.1.1 Global Bulk Drug Intermediates Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bulk Drug Intermediates Annual Revenue by Geographic Region
4.2 World Historic Bulk Drug Intermediates Market Size by Country/Region (2017-2022)
4.2.1 Global Bulk Drug Intermediates Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bulk Drug Intermediates Annual Revenue by Country/Region
4.3 Americas Bulk Drug Intermediates Sales Growth
4.4 APAC Bulk Drug Intermediates Sales Growth
4.5 Europe Bulk Drug Intermediates Sales Growth
4.6 Middle East & Africa Bulk Drug Intermediates Sales Growth
5 Americas
5.1 Americas Bulk Drug Intermediates Sales by Country
5.1.1 Americas Bulk Drug Intermediates Sales by Country (2017-2022)
5.1.2 Americas Bulk Drug Intermediates Revenue by Country (2017-2022)
5.2 Americas Bulk Drug Intermediates Sales by Type
5.3 Americas Bulk Drug Intermediates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bulk Drug Intermediates Sales by Region
6.1.1 APAC Bulk Drug Intermediates Sales by Region (2017-2022)
6.1.2 APAC Bulk Drug Intermediates Revenue by Region (2017-2022)
6.2 APAC Bulk Drug Intermediates Sales by Type
6.3 APAC Bulk Drug Intermediates Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bulk Drug Intermediates by Country
7.1.1 Europe Bulk Drug Intermediates Sales by Country (2017-2022)
7.1.2 Europe Bulk Drug Intermediates Revenue by Country (2017-2022)
7.2 Europe Bulk Drug Intermediates Sales by Type
7.3 Europe Bulk Drug Intermediates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bulk Drug Intermediates by Country
8.1.1 Middle East & Africa Bulk Drug Intermediates Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bulk Drug Intermediates Revenue by Country (2017-2022)
8.2 Middle East & Africa Bulk Drug Intermediates Sales by Type
8.3 Middle East & Africa Bulk Drug Intermediates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bulk Drug Intermediates
10.3 Manufacturing Process Analysis of Bulk Drug Intermediates
10.4 Industry Chain Structure of Bulk Drug Intermediates
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bulk Drug Intermediates Distributors
11.3 Bulk Drug Intermediates Customer
12 World Forecast Review for Bulk Drug Intermediates by Geographic Region
12.1 Global Bulk Drug Intermediates Market Size Forecast by Region
12.1.1 Global Bulk Drug Intermediates Forecast by Region (2023-2028)
12.1.2 Global Bulk Drug Intermediates Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bulk Drug Intermediates Forecast by Type
12.7 Global Bulk Drug Intermediates Forecast by Application
13 Key Players Analysis
13.1 Lonza
13.1.1 Lonza Company Information
13.1.2 Lonza Bulk Drug Intermediates Product Offered
13.1.3 Lonza Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lonza Main Business Overview
13.1.5 Lonza Latest Developments
13.2 Catalent
13.2.1 Catalent Company Information
13.2.2 Catalent Bulk Drug Intermediates Product Offered
13.2.3 Catalent Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Catalent Main Business Overview
13.2.5 Catalent Latest Developments
13.3 Patheon
13.3.1 Patheon Company Information
13.3.2 Patheon Bulk Drug Intermediates Product Offered
13.3.3 Patheon Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Patheon Main Business Overview
13.3.5 Patheon Latest Developments
13.4 Jubilant
13.4.1 Jubilant Company Information
13.4.2 Jubilant Bulk Drug Intermediates Product Offered
13.4.3 Jubilant Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jubilant Main Business Overview
13.4.5 Jubilant Latest Developments
13.5 Granules
13.5.1 Granules Company Information
13.5.2 Granules Bulk Drug Intermediates Product Offered
13.5.3 Granules Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Granules Main Business Overview
13.5.5 Granules Latest Developments
13.6 Ganesh
13.6.1 Ganesh Company Information
13.6.2 Ganesh Bulk Drug Intermediates Product Offered
13.6.3 Ganesh Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ganesh Main Business Overview
13.6.5 Ganesh Latest Developments
13.7 Chemcon
13.7.1 Chemcon Company Information
13.7.2 Chemcon Bulk Drug Intermediates Product Offered
13.7.3 Chemcon Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chemcon Main Business Overview
13.7.5 Chemcon Latest Developments
13.8 BASF
13.8.1 BASF Company Information
13.8.2 BASF Bulk Drug Intermediates Product Offered
13.8.3 BASF Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 BASF Main Business Overview
13.8.5 BASF Latest Developments
13.9 Porton
13.9.1 Porton Company Information
13.9.2 Porton Bulk Drug Intermediates Product Offered
13.9.3 Porton Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Porton Main Business Overview
13.9.5 Porton Latest Developments
13.10 Lianhetech
13.10.1 Lianhetech Company Information
13.10.2 Lianhetech Bulk Drug Intermediates Product Offered
13.10.3 Lianhetech Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lianhetech Main Business Overview
13.10.5 Lianhetech Latest Developments
13.11 ABA Chem
13.11.1 ABA Chem Company Information
13.11.2 ABA Chem Bulk Drug Intermediates Product Offered
13.11.3 ABA Chem Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 ABA Chem Main Business Overview
13.11.5 ABA Chem Latest Developments
13.12 Tianma
13.12.1 Tianma Company Information
13.12.2 Tianma Bulk Drug Intermediates Product Offered
13.12.3 Tianma Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Tianma Main Business Overview
13.12.5 Tianma Latest Developments
13.13 Jiujiujiu
13.13.1 Jiujiujiu Company Information
13.13.2 Jiujiujiu Bulk Drug Intermediates Product Offered
13.13.3 Jiujiujiu Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jiujiujiu Main Business Overview
13.13.5 Jiujiujiu Latest Developments
13.14 Alpha
13.14.1 Alpha Company Information
13.14.2 Alpha Bulk Drug Intermediates Product Offered
13.14.3 Alpha Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Alpha Main Business Overview
13.14.5 Alpha Latest Developments
13.15 Jiuzhou
13.15.1 Jiuzhou Company Information
13.15.2 Jiuzhou Bulk Drug Intermediates Product Offered
13.15.3 Jiuzhou Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Jiuzhou Main Business Overview
13.15.5 Jiuzhou Latest Developments
13.16 Yongtai
13.16.1 Yongtai Company Information
13.16.2 Yongtai Bulk Drug Intermediates Product Offered
13.16.3 Yongtai Bulk Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Yongtai Main Business Overview
13.16.5 Yongtai Latest Developments
14 Research Findings and Conclusion
Table 1. Bulk Drug Intermediates Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bulk Drug Intermediates Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of GMP
Table 4. Major Players of Non-GMP
Table 5. Global Bulk Drug Intermediates Sales by Type (2017-2022) & (K Units)
Table 6. Global Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
Table 7. Global Bulk Drug Intermediates Revenue by Type (2017-2022) & ($ million)
Table 8. Global Bulk Drug Intermediates Revenue Market Share by Type (2017-2022)
Table 9. Global Bulk Drug Intermediates Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Bulk Drug Intermediates Sales by Application (2017-2022) & (K Units)
Table 11. Global Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Table 12. Global Bulk Drug Intermediates Revenue by Application (2017-2022)
Table 13. Global Bulk Drug Intermediates Revenue Market Share by Application (2017-2022)
Table 14. Global Bulk Drug Intermediates Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Bulk Drug Intermediates Sales by Company (2020-2022) & (K Units)
Table 16. Global Bulk Drug Intermediates Sales Market Share by Company (2020-2022)
Table 17. Global Bulk Drug Intermediates Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bulk Drug Intermediates Revenue Market Share by Company (2020-2022)
Table 19. Global Bulk Drug Intermediates Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Bulk Drug Intermediates Producing Area Distribution and Sales Area
Table 21. Players Bulk Drug Intermediates Products Offered
Table 22. Bulk Drug Intermediates Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bulk Drug Intermediates Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Bulk Drug Intermediates Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bulk Drug Intermediates Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bulk Drug Intermediates Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bulk Drug Intermediates Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Bulk Drug Intermediates Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bulk Drug Intermediates Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bulk Drug Intermediates Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bulk Drug Intermediates Sales by Country (2017-2022) & (K Units)
Table 34. Americas Bulk Drug Intermediates Sales Market Share by Country (2017-2022)
Table 35. Americas Bulk Drug Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bulk Drug Intermediates Revenue Market Share by Country (2017-2022)
Table 37. Americas Bulk Drug Intermediates Sales by Type (2017-2022) & (K Units)
Table 38. Americas Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
Table 39. Americas Bulk Drug Intermediates Sales by Application (2017-2022) & (K Units)
Table 40. Americas Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Table 41. APAC Bulk Drug Intermediates Sales by Region (2017-2022) & (K Units)
Table 42. APAC Bulk Drug Intermediates Sales Market Share by Region (2017-2022)
Table 43. APAC Bulk Drug Intermediates Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bulk Drug Intermediates Revenue Market Share by Region (2017-2022)
Table 45. APAC Bulk Drug Intermediates Sales by Type (2017-2022) & (K Units)
Table 46. APAC Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
Table 47. APAC Bulk Drug Intermediates Sales by Application (2017-2022) & (K Units)
Table 48. APAC Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Table 49. Europe Bulk Drug Intermediates Sales by Country (2017-2022) & (K Units)
Table 50. Europe Bulk Drug Intermediates Sales Market Share by Country (2017-2022)
Table 51. Europe Bulk Drug Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bulk Drug Intermediates Revenue Market Share by Country (2017-2022)
Table 53. Europe Bulk Drug Intermediates Sales by Type (2017-2022) & (K Units)
Table 54. Europe Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
Table 55. Europe Bulk Drug Intermediates Sales by Application (2017-2022) & (K Units)
Table 56. Europe Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bulk Drug Intermediates Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Bulk Drug Intermediates Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bulk Drug Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bulk Drug Intermediates Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bulk Drug Intermediates Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Bulk Drug Intermediates Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Bulk Drug Intermediates Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bulk Drug Intermediates
Table 66. Key Market Challenges & Risks of Bulk Drug Intermediates
Table 67. Key Industry Trends of Bulk Drug Intermediates
Table 68. Bulk Drug Intermediates Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bulk Drug Intermediates Distributors List
Table 71. Bulk Drug Intermediates Customer List
Table 72. Global Bulk Drug Intermediates Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Bulk Drug Intermediates Sales Market Forecast by Region
Table 74. Global Bulk Drug Intermediates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bulk Drug Intermediates Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bulk Drug Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Bulk Drug Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bulk Drug Intermediates Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Bulk Drug Intermediates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bulk Drug Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Bulk Drug Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bulk Drug Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Bulk Drug Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bulk Drug Intermediates Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Bulk Drug Intermediates Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Bulk Drug Intermediates Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Bulk Drug Intermediates Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Bulk Drug Intermediates Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Bulk Drug Intermediates Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bulk Drug Intermediates Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bulk Drug Intermediates Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lonza Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 93. Lonza Bulk Drug Intermediates Product Offered
Table 94. Lonza Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lonza Main Business
Table 96. Lonza Latest Developments
Table 97. Catalent Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 98. Catalent Bulk Drug Intermediates Product Offered
Table 99. Catalent Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Catalent Main Business
Table 101. Catalent Latest Developments
Table 102. Patheon Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 103. Patheon Bulk Drug Intermediates Product Offered
Table 104. Patheon Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Patheon Main Business
Table 106. Patheon Latest Developments
Table 107. Jubilant Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 108. Jubilant Bulk Drug Intermediates Product Offered
Table 109. Jubilant Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Jubilant Main Business
Table 111. Jubilant Latest Developments
Table 112. Granules Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 113. Granules Bulk Drug Intermediates Product Offered
Table 114. Granules Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Granules Main Business
Table 116. Granules Latest Developments
Table 117. Ganesh Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 118. Ganesh Bulk Drug Intermediates Product Offered
Table 119. Ganesh Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Ganesh Main Business
Table 121. Ganesh Latest Developments
Table 122. Chemcon Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 123. Chemcon Bulk Drug Intermediates Product Offered
Table 124. Chemcon Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Chemcon Main Business
Table 126. Chemcon Latest Developments
Table 127. BASF Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 128. BASF Bulk Drug Intermediates Product Offered
Table 129. BASF Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. BASF Main Business
Table 131. BASF Latest Developments
Table 132. Porton Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 133. Porton Bulk Drug Intermediates Product Offered
Table 134. Porton Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Porton Main Business
Table 136. Porton Latest Developments
Table 137. Lianhetech Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 138. Lianhetech Bulk Drug Intermediates Product Offered
Table 139. Lianhetech Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Lianhetech Main Business
Table 141. Lianhetech Latest Developments
Table 142. ABA Chem Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 143. ABA Chem Bulk Drug Intermediates Product Offered
Table 144. ABA Chem Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. ABA Chem Main Business
Table 146. ABA Chem Latest Developments
Table 147. Tianma Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 148. Tianma Bulk Drug Intermediates Product Offered
Table 149. Tianma Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Tianma Main Business
Table 151. Tianma Latest Developments
Table 152. Jiujiujiu Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 153. Jiujiujiu Bulk Drug Intermediates Product Offered
Table 154. Jiujiujiu Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Jiujiujiu Main Business
Table 156. Jiujiujiu Latest Developments
Table 157. Alpha Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 158. Alpha Bulk Drug Intermediates Product Offered
Table 159. Alpha Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Alpha Main Business
Table 161. Alpha Latest Developments
Table 162. Jiuzhou Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 163. Jiuzhou Bulk Drug Intermediates Product Offered
Table 164. Jiuzhou Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Jiuzhou Main Business
Table 166. Jiuzhou Latest Developments
Table 167. Yongtai Basic Information, Bulk Drug Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 168. Yongtai Bulk Drug Intermediates Product Offered
Table 169. Yongtai Bulk Drug Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Yongtai Main Business
Table 171. Yongtai Latest Developments
List of Figures
Figure 1. Picture of Bulk Drug Intermediates
Figure 2. Bulk Drug Intermediates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bulk Drug Intermediates Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bulk Drug Intermediates Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bulk Drug Intermediates Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of GMP
Figure 10. Product Picture of Non-GMP
Figure 11. Global Bulk Drug Intermediates Sales Market Share by Type in 2021
Figure 12. Global Bulk Drug Intermediates Revenue Market Share by Type (2017-2022)
Figure 13. Bulk Drug Intermediates Consumed in Antibiotics
Figure 14. Global Bulk Drug Intermediates Market: Antibiotics (2017-2022) & (K Units)
Figure 15. Bulk Drug Intermediates Consumed in Antipyretic Analgesics
Figure 16. Global Bulk Drug Intermediates Market: Antipyretic Analgesics (2017-2022) & (K Units)
Figure 17. Bulk Drug Intermediates Consumed in Vitamins
Figure 18. Global Bulk Drug Intermediates Market: Vitamins (2017-2022) & (K Units)
Figure 19. Bulk Drug Intermediates Consumed in Others
Figure 20. Global Bulk Drug Intermediates Market: Others (2017-2022) & (K Units)
Figure 21. Global Bulk Drug Intermediates Sales Market Share by Application (2017-2022)
Figure 22. Global Bulk Drug Intermediates Revenue Market Share by Application in 2021
Figure 23. Bulk Drug Intermediates Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Bulk Drug Intermediates Revenue Market Share by Company in 2021
Figure 25. Global Bulk Drug Intermediates Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Bulk Drug Intermediates Revenue Market Share by Geographic Region in 2021
Figure 27. Global Bulk Drug Intermediates Sales Market Share by Region (2017-2022)
Figure 28. Global Bulk Drug Intermediates Revenue Market Share by Country/Region in 2021
Figure 29. Americas Bulk Drug Intermediates Sales 2017-2022 (K Units)
Figure 30. Americas Bulk Drug Intermediates Revenue 2017-2022 ($ Millions)
Figure 31. APAC Bulk Drug Intermediates Sales 2017-2022 (K Units)
Figure 32. APAC Bulk Drug Intermediates Revenue 2017-2022 ($ Millions)
Figure 33. Europe Bulk Drug Intermediates Sales 2017-2022 (K Units)
Figure 34. Europe Bulk Drug Intermediates Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Bulk Drug Intermediates Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Bulk Drug Intermediates Revenue 2017-2022 ($ Millions)
Figure 37. Americas Bulk Drug Intermediates Sales Market Share by Country in 2021
Figure 38. Americas Bulk Drug Intermediates Revenue Market Share by Country in 2021
Figure 39. United States Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Bulk Drug Intermediates Sales Market Share by Region in 2021
Figure 44. APAC Bulk Drug Intermediates Revenue Market Share by Regions in 2021
Figure 45. China Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Bulk Drug Intermediates Sales Market Share by Country in 2021
Figure 52. Europe Bulk Drug Intermediates Revenue Market Share by Country in 2021
Figure 53. Germany Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Bulk Drug Intermediates Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Bulk Drug Intermediates Revenue Market Share by Country in 2021
Figure 60. Egypt Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Bulk Drug Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Bulk Drug Intermediates in 2021
Figure 66. Manufacturing Process Analysis of Bulk Drug Intermediates
Figure 67. Industry Chain Structure of Bulk Drug Intermediates
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...